Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-24-000639
Filing Date
2024-08-14
Accepted
2024-08-14 20:45:41
Documents
1
Group Members
ALI BEHBAHANIANTHONY A. FLORENCE, JR.CARMEN CHANGEDWARD T. MATHERSFOREST BASKETTMOHAMAD H. MAKHZOUMINEA 17 GP, LLCNEA PARTNERS 17, L.P.NEW ENTERPRISE ASSOCIATES 17, L.P.PAUL WALKERRICK YANGSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 GROWTH EQUITY OPPORTUNITIES 17, LLC / SAVARA INC -- 13D/A(#2) geo17-savara_18865.htm SC 13D/A 476731
  Complete submission text file 0001072613-24-000639.txt   479072
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-78541 | Film No.: 241210299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities 17, LLC (Filed by) CIK: 0001790256 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A